CVS/Caremark July 1, 2020 Formulary Update

July 1, 2020

CVS/Caremark July 1, 2020 Formulary Update

As a follow-up to the June 10th update regarding the Formulary update that takes effect today, Caremark provided the additional detailed information below.

In Caremark’s ongoing effort to assist our Plan in maximizing our health care investment while offering your plan members clinically appropriate prescription therapy, Caremark announced changes to the Standard Formulary effective July 1st, 2020. A copy of the Performance Drug List can be found here.  ***Please note, although Contraceptives are listed on the formulary, our plan does not cover these drugs.*** 

The formulary review process focused on many factors, including:

1.Adding products that have demonstrated enhanced clinical efficacy and/or provide more convenient dosage forms.  Tier 2 (Preferred):

BAQSIMI NASAL POWDER EMGALITY PFS NURTEC ORALLY DISINTEGRATING TABLET (ODT) PRALUENT PEN/INJECTION RYBELSUS TABLET SYMJEPI INJECTION TAKHZYRO VIAL VUMERITY CAPSULE

BRYHALI LOTION LO LOESTRIN FE TABLET ONEXTON GEL REYVOW TABLET STELARA VIAL SYMTUZA TABLET UBRELVY TABLET YUPELRI SOLUTION

 

2.Removing products that may have less convenient dosage forms, may have more side effects or may cost more when compared to available options on the CVS Caremark® Drug List.  Please note some of the exclusions have been previously communicated.

 a. Formulary Exclusions:

BELVIQ TABLET BELVIQ XR TABLET BIMATOPROST OPHTHALMIC SOLUTION BUPROPION 450MG XL TABLET CHLORZOXAZONE 375MG TABLET CHLORZOXAZONE 750MG TABLET CLINDAMYCIN GEL COREMINO TABLET CYCLOBENZAPRINE ER CAPSULE DOXYCYCLINE HYCLATE 150MG TABLET DOXYCYCLINE HYCLATE 200MG DR TABLET DOXYCYCLINE HYCLATE 50MG TABLET DOXYCYCLINE HYCLATE 75MG TABLET DOXYCYCLINE MONOHYDRATE 150MG CAPSULE DOXYCYCLINE MONOHYDRATE 75MG CAPSULE ERGOTAMINE-CAFFEINE TABLET FLUCYTOSINE 500MG CAPSULE

FLUOXETINE 60MG TABLET FLURANDRENOL LOTION HYDROCORTISONE BUTYRATE CREAM HYDROCORTISONE BUTYRATE LIPID CREAM KETOPROFEN 25MG CAPSULE LORZONE TABLET MINOCYCLINE ER TABLET MONDOXYNE NL 75MG CAPSULE OKEBO 75MG CAPSULE ORPHENADRINE CITRATE-ASPIRIN-CAFFEINE TABLET ORPHENGESIC FORTE TABLET POSACONAZOLE DR TABLET REPATHA PUSHTRONEX SYSTEM REPATHA SURECLICK PEN REPATHA SYRINGE SUMATRIPTAN-NAPROXEN TABLET TREXIMET TABLET TRIAMCINOLONE TOPICAL SPRAY

b. Tier 2 to Tier 3:

APRISO CAPSULE ESGIC APAP TABLET MIRCETTE TABLET NUVARING VAGINAL RING ULORIC TABLET ZANAFLEX TABLET

DAYPRO TABLET ISORDIL TITRADOSE TABLET MOBIC TABLET SENSIPAR TABLET ULTRAM TABLET

Mailing Process:

As always, notifications are sent to members who are negatively affected by tier changes or drug exclusions. Please encourage your members to use the CVS Caremark website, Caremark.com, to view the most current version of the drug list, as well as to review their prescription drug benefit information, request mail service orders and research drug information.

 

We appreciate the opportunity to serve you and your members’ prescription benefit needs. If you have any questions regarding these changes, please do not hesitate to contact the Trust!